A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis (Q40519520)
Jump to navigation
Jump to search
scientific article published on December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis |
scientific article published on December 2004 |
Statements
1 reference
A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis (English)
1 reference
M Patricia Leuschen
1 reference
Mary Filipi
1 reference
Kathleen Healey
1 reference
1 December 2004
1 reference
1 reference
10
1 reference
6
1 reference
636-642
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference